Quantcast

Latest Crescendo Biologics Limited Stories

2014-04-03 04:20:52

CAMBRIDGE, England, April 3, 2014 /PRNewswire/ -- GBP19.5M raised to drive development of best-in-class fully human VH antibody fragment therapeutics Crescendo Biologics Limited (Crescendo) today announces it has raised a further GBP2m ($3.3m), from EMBL Ventures, in a final close of its Series A financing. Originally announced in December 2013, the Series A now totals GBP19.5m. It was led by Imperial Innovations and included new...

2014-03-28 04:21:52

CAMBRIDGE, England, March 28, 2014 /PRNewswire/ -- Crescendo Biologics Limited (Crescendo) today announces it has been awarded the prize for Business Innovation at the Cambridge News Business Excellence Awards 2014. During 2013, Crescendo announced the Crescendo Mouse, a breakthrough in antibody fragment technology which allows the efficient generation of high-quality fully human single domain antibody VH fragments from a transgenic mouse. The Company also raised...

2011-06-22 03:00:00

CAMBRIDGE, England, June 21, 2011 /PRNewswire/ -- Crescendo Biologics Limited (Crescendo) today announces the appointment of Matthew Roe as Chief Business Officer. Matthew joins Crescendo from Genzyme Corporation where he was Senior Director, Business Development & Licensing. During a 23-year career at Genzyme, Matthew was active in licensing, alliance management, acquisition, divestment, and sales and marketing, and saw the corporation develop from an entrepreneurial...

2011-01-05 06:23:00

CAMBRIDGE, England, January 5, 2011 /PRNewswire/ -- Crescendo Biologics Limited (Crescendo) today announces the appointment of Mike Romanos as Chief Executive Officer. Dr Romanos has been Chief Scientific Officer of the company since May 2009 and has led the formation of the company and the development of its proprietary antibody fragment technologies. During this time, the company has made significant progress in the establishment of its team and its technology platforms. This has...

2010-09-29 02:58:00

CAMBRIDGE, England, September 29, 2010 /PRNewswire/ -- - Mice Lacking Endogenous Antibody Polypeptides Offer Powerful New Tool for Antibody Fragment Development Crescendo Biologics Limited (Crescendo) today announces it has established a colony of engineered mice completely devoid of endogenous antibody polypeptides. The proprietary 'triple knockout' mice are believed to be unique and have the immunoglobulin heavy chain (IgH), kappa light chain and lambda light chain loci all...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related